I want to introduce you to my colleague Dr. Janis Enzenbacher. Dr. Enzenbacher is certified by the American Academy of Facial Esthetics to administer Botox(neurotoxin), Dermal Filler, Solid Filler Smoothing and Lifting Threads (PDO Threads).
Semaglutide for Weight LossHave you tried to lose weight only to be frustrated by the "yo-yo" effect? |
|
|
|
|
|
There is a safe and effective medication, SEMAGLUTIDE that can bring you weight loss you desire. It is a peptide made of a series of amino acids. The protocol is done in 3 month increments until desired weight loss is achieved. In conjunction with a recommended diet and exercise program which will be discussed at your initial appointment, the semaglutide can significantly enhance your weight loss. You can expect to increase your weight loss by up to 15% over a 3-6-month period. Individuals who are overweight or obese and achieve weight loss of ≥5% of their initial body weight can reduce their blood pressure, LDL, triglycerides, blood sugar as well as prevent Type 2 diabetes mellitus. If you have pre- diabetes, diabetes, high blood pressure, and or elevated LDL, this medication can help treat and reverse these conditions. Most weight loss will occur within the first 6 months of your semaglutide weight loss journey. The medication is generally well tolerated and can continue to be part of your weight loss regime until your desired goal is reached. Over your three-month protocol you will self-administer the medication once weekly with a syringe attached to a very short, thin needle, under the skin. Dr. Enzenbacher will instruct you during your first visit. The dose will be gradually increased to minimize common side effects. At your first appointment, Janis L. Enzenbacher, MD will discuss your weight loss goals and lifestyle. Your height, weight and % body fat will be recorded. Each month you will get a new supply and the measurements will be repeated to track progress. Dr. Enzenbacher may require you to receive appropriate blood work to assess you HgbA1C (blood sugar over 3 months), thyroid function tests, and lipid profile, |
|
|
|
|
|
WHAT DOES SEMAGLUTIDE DO:
Semaglutide is a glucagon like peptide (GLP1) which positively affects the reward pathway. This medication was originally developed for the treatment of Type 2 diabetes and has now been approved by the FDA for people with obesity and/or at least one obesity related comorbidity such as several cardio metabolic disorders which drives significant morbidity and premature mortality. |
|
|
|
|
|
FAQ:
Semaglutide controls the appetite through the GLP1 receptors in the brain. GLP1 is a hormone and acts upon cells in the GI tract where it stimulates the release of insulin. It controls appetite by slowing the emptying time of the stomach. Studies have shown that once weekly dosing of 2.4 semaglutide provides safe, well tolerated and substantial weight loss for individuals who are overweight or are obese. Is it FDA approved: 2.4 mg weekly injection has been approved by the U.S. FDA as of June 2021 for the chronic management of people who are obese, overweight and at least one weight related comorbidity. What are the Side Effects? *Note: please notify your doctor if you are experiencing any of these side effects. Are there other benefits of Semaglutide? Other benefits include:
|
|
|
|
|
|
If you are interested in Semaglutide for weight loss please follow the links below to contact Dr. Enzenbacher.
|
I have treated firefighters for the past 15 years, blogged about their increased risk of cancer and cardiovascular disease and now about their obesity associated mortality.
Plagues and infectious diseases that were previously the leading causes of death were largely eliminated with medical advances like vaccines and improvements in living conditions. Now, instead, we are plagued by chronic degenerative diseases. Several changes have occurred since the end of World War II that have contributed to the decline of our microbiomes and, from that, dysbiosis and the development of disease.
Our physical and mental health are largely dependent on the balance of the gastrointestinal (GI) system because of the gut-brain connection between the intestinal tract and the brain. Dysbiosis, the “disruption of the intestinal microbial ecosystem,” can cause GI, neurological, cardiovascular, and several other types of diseases. So, it is important for our health that our intestinal microbiomes are rich and diverse.
| Almost half of the U.S. adult population is obese. Obesity can result from diet, lack of physical activity, socioeconomic factors, genetics, and even chemicals in the environment. Low level exposure to obesogenic chemicals, found in food, water, air, etc., contributes to obesity, and can also affect hormone activity, metabolism, and fat cell formation. The main chemicals include: BPA, phthalates, PBDEs, PFCs, OC pesticides, and PCBs. |
So many conflicting published reports from scientific Ivory Towers. Now a savvy 9 year old can verify facts and #TrackTheTruth
I have treated firefighters for the past 15 years, blogged about their increased risk of cancer and cardiovascular disease and now about their obesity associated mortality.